Has Mobeen Choudhri, MD received payments from drug or device companies?

Yes. Drug and device makers reported $60,591 in general payments to Mobeen Choudhri, MD across 1,452 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mobeen Choudhri, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mobeen Choudhri, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mobeen Choudhri, MD

Interventional Pain Medicine · Bellaire, TXNPI 1942347877

Payments from drug & device makers

$60,591in general payments, 2019–2025

Across 1,452 payments — averaging $41.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$24K
Si-bone, Inc.$7K
Boston Scientific$6K
Abbott$4K
Nevro Corp.$2K
Saluda Medical Americas, Inc.$2K
plus $15K from 50 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(3 entities)	439	$24,048
Si-bone, Inc.	72	$6,666
Boston Scientific	135	$6,143
Abbott	145	$4,351
Nevro Corp.	40	$2,132
Saluda Medical Americas, Inc.	17	$2,116
AbbVie(2 entities)	100	$1,819
Relievant Medsystems, Inc.	11	$1,228
SPR Therapeutics, Inc	8	$1,117
Vertos Medical, Inc.	22	$987
Teva Pharmaceuticals USA, Inc.	38	$937
Biotronik NRO, Inc.	37	$886
Pfizer	65	$846
Collegium Pharmaceutical, Inc.	46	$574
Amgen(2 entities)	20	$563
Nalu Medical, Inc.	11	$535
Pacira Pharmaceuticals Incorporated	6	$530
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	29	$498
Scilex Pharmaceuticals Inc.	18	$393
Lilly USA, LLC	22	$327
Eisai Inc.	18	$322
Stryker	3	$281
Merz North America, Inc.	9	$262
Daiichi Sankyo Inc.	14	$220
Bioventus LLC	3	$201
Biodelivery Sciences International, Inc.	15	$199
Lundbeck LLC	8	$190
Novartis	13	$184
Averitas Pharma Inc.	8	$166
Merz Pharmaceuticals, LLC	8	$158
Arbor Pharmaceuticals, Inc.	9	$158
Zynex Medical, Inc.	1	$155
Globus Medical	2	$132
Biohaven Pharmaceutical Holding Company Ltd.	7	$119
Foundation Fusion Solutions, LLC	1	$110
Electronic Waveform Lab, Inc.	1	$104
Tersera Therapeutics LLC	6	$98
Painteq LLC	3	$96
Fujifilm Sonosite, Inc.	1	$95
Pacira Therapeutics, Inc.	4	$73
Takeda Pharmaceuticals U.S.A., Inc.	6	$66
Idorsia Pharmaceuticals US Inc	4	$65
Zyla Life Sciences, Inc.	3	$51
MDD US Operations, LLC	3	$47
Fidia Pharma USA Inc.	2	$42
AstraZeneca	3	$41
Supernus Pharmaceuticals, Inc.	2	$39
Assertio Therapeutics, Inc.	2	$38
Inspire Medical Systems, Inc.	1	$31
Tactile Systems Technology Inc	2	$30
Impel Pharmaceuticals Inc.	2	$30
Bausch Health US, LLC	2	$29
GRT US Holding, Inc.	2	$24
Shionogi Inc	1	$19
Vertiflex, Inc.	1	$11
Biocomposites Inc	1	$10

How this compares

$60,591 in reported general payments places this provider in the 90th percentile of 287 interventional pain medicine providers in Texas.

See all interventional pain medicine providers in Texas →

Medicare billing

Part B allowed, 2024

$2,150,786

Medicare patients

418

Services billed

6,726

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Bellaire

Gabor RaczLubbock$3M
Pankaj MehtaKilleen$2.2M
Genaro GutierrezAustin$1.3M
Chad StephensSouthlake$1.1M
Ioannis SkaribasHouston$979K
Duane GriffithTyler$730K
Brannon FrankAustin$698K
Robert WillsRound Rock$692K
Ankur KhoslaShenandoah$511K
Brian RichDecatur$245K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →